Canada Pension Plan Investment Board’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Canada Pension Plan Investment Board’s Portfolio RXDX Stock Details RXDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-41,000	Closed	-$4.4M	–	1129
2023 Q1	$4.4M	Hold	41,000	–	–	0.01%	603
2022 Q4	$4.51M	Buy	+41,000	New	+$2.66M	0.01%	545

Other funds holding RXDX

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

FCA

FinTrust Capital Advisors Greenville, South Carolina $591M AUM 26.89% 1-Year Est. Return

Canada Pension Plan Investment Board's RXDX Position: Q2 2023 in Review

Canada Pension Plan Investment Board sold out of Prometheus Biosciences, Inc. Common Stock (RXDX) in Q2 2023, closing a stake of 41,000 shares — an estimated $4.4M sold.

Canada Pension Plan Investment Board first reported a position in RXDX in Q4 2022 and held it in 2 quarters. The position peaked at $4.51M in Q4 2022. 2 funds tracked by Wall St. Rank hold RXDX as of Q2 2023.

Canada Pension Plan Investment Board reported no remaining Prometheus Biosciences, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Canada Pension Plan Investment Board sold 41,000 Prometheus Biosciences, Inc. Common Stock shares in Q2 2023, an estimated $4.4M.
Canada Pension Plan Investment Board first reported a position in Prometheus Biosciences, Inc. Common Stock in Q4 2022 and held it in 2 quarters.
Canada Pension Plan Investment Board's Prometheus Biosciences, Inc. Common Stock position peaked at $4.51M in Q4 2022.
2 funds tracked by Wall St. Rank held Prometheus Biosciences, Inc. Common Stock as of Q2 2023.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2023, filed 9 Aug 2023.